One-pot regioselective synthesis of 2I,3I-O-(o-xylylene)-capped cyclomaltooligosaccharides: tailoring the topology and supramolecular properties of cyclodextrins by Balbuena Olivia, Patricia et al.
 S1
Supplementary Information 
 
One-Pot Regioselective Synthesis of 2I,3I-O-(o-Xylylene)-Capped 
Cyclomaltooligosaccharides: Tailoring the Topology and Supramolecular Properties of 
Cyclodextrins 
 
Patricia Balbuena,a David Lesur,b M. José González Álvarez,c Francisco Mendicuti,c 
Carmen Ortiz Mellet,*a and José M. García Fernández*d 
 
 Materials and General Methods. All solvents and reagents were purchased from commercial 
sources and used without further purification, except for dichloromethane, which was distilled under Ar 
stream over CaH2, pyridine, which was dried over KOH and distilled, DMF, which was dried over BaO, 
distilled and kept over 4 Å molecular sieves, and DMSO, which was distilled and kept over 4 Å 
molecular sieves. α, β and γCD were commercial compounds; they were dried over P2O5 at 85 ºC under 
vacuum until constant weight before using. Optical rotations were measured at 20 ºC in 1-cm or 1-dm 
tubes. 1H (and 13C NMR) spectra were recorded at 500 (125.7) MHz. 2D COSY, 2D NOESY, 1D 
TOCSY, HMQC and HSQC experiments were used to assist on NMR assignments. Thin-layer 
chromatography (TLC) was carried out on aluminium sheets coated with Kieselgel 60 F254 (E. Merck), 
with visualisation by UV light and by charring with 10% H2SO4. Analytical HPLC was carried out on a 
Waters 600 instrument provided with an on-line degasser and a DEDL PL ELS 1000 detector from 
Polymer Laboratories. The Waters chemstation used Empower software. Alltech Carbohydrate ES 5u 
(5μm particle size, 250 mm x 4,6 mm) and Alltech Prevail C18 5u (5μm particle size, 250 mm x 4,6 mm) 
columns were used. Column chromatography was carried out on Silica Gel 60 (E. Merck, 230-400 mesh). 
The operating conditions for recording FAB mass spectra were the following: the primary beam consisted 
of Xe atoms with a maximum energy of 8 keV; the samples were dissolved in thioglycerol, and the 
positive ions were separated and accelerated over a potential of 7 keV; NaI was added as cationizing 
agent. MALDI-TOF mass spectra were acquired on a spectrometer operating in the positive-ion mode 
with an accelerating voltage of 28 keV. Samples were dissolved in acetonitrile at mM concentration and 
mixed with a standard solution of α-cyano-4-hydroxycinnamic acid (α-cyano; 20 mg mL–1 in 25:25:1 
MeOH-H2O-AcOH, 2 μL); 1 μL of the mixture was loaded onto the target plate, then allowed to airdryat 
room temperature. For ESI mass spectra, 0.1 pM sample concentration were used, the mobile phase 
consisting of 50% aq acetonitrile at 0.1 mL min-1. Elemental analyses were performed at the Instituto de 
Investigaciones Químicas (Sevilla, Spain). Calculations were performed with the MACROMODEL 6.0 
package using the MM2* force field and the GB/SA continuous solvent model for water. 
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2I,3I-O-(o-Xylylene)cyclomaltohexaose (4). Isolated as white needles after crystallisation from 
water (Found: C, 48.99; H, 5.95; C44H66O30 requires: C, 49.16; H, 6.19); Rf = 0.54 (6:3:1 CH3CN-H2O-
NH4OH); [α]D = +152.2 (c 1.0 in DMSO); 1H NMR (500 MHz, D2O, 333 K): δ = 7.70-7.63 (m, 4 H, Ph), 
5.48 (d, 1 H, J1,2 = 3.7 Hz, H-1I), 5.46, 5.40 (2 d, 2 H, 2JH,H = 14.6 Hz, CHPh), 5.43, 5.30 (2 d, 2 H, 2JH,H = 
13.7 Hz, CHPh), 5.37-5.28 (m, 5 H, H-1II-VI), 4.41-3.98 (m, 26 H, H-3I-VI, H-6aI-VI, H-6bI-VI, H-5I-VI, H-2I, 
H-4I), 3.98-3.88 (m, 5 H, H-2II-VI), 3.91-3.78 (m, 5 H, H-4II-VI); 1H TOCSY (H-1I irradiation): δ = 4.29 (d, 1 
H, J6a,6b = 12.5 Hz, H-6aI), 4.25 (dd, 1 H, J5,6b = 3.0 Hz, H-6bI), 4.21 (t, 1 H, J2,3 = J3,4 = 9.0 Hz, H-3I), 4.14 
(m, 1 H, H-5I), 4.05 (dd, 1 H, H-2I),  4.03 (t, 1 H, J4,5 = 9.5 Hz, H-4I); 13C NMR (125.7 MHz, D2O, 333 K): 
δ = 136.9-128.6 (Ph), 102.0, 101.9, 101.8, 101.7, 101.6 (5 C, C-1II-VI), 100.9 (C-1I), 82.5, 82.0, 81.9 (×2), 
81.8 (5 C, C-4II-VI), 80.8 (C-3I), 80.4 (C-4I), 79.5 (C-2I), 74.2, 74.0 (×2), 73.8, 73.6 (5 C, C-3II-VI), 73.8 
(CH2Ph), 72.8, 72.7 (×3), 72.5 (5 C, C-5II-VI), 72.7 (CH2Ph), 72.3, 72.2 (×2), 72.1, 71.9 (5 C, C-2II-VI), 61.0 
(×6) (6 C, C-6I-VI); ESIMS: m/z 1113.2 ([M + Na]+). 
2I,3I-O-(o-Xylylene)cyclomaltoheptaose (5). Isolated as an amorphous solid (Found: C, 48.38; H, 
5.96; C50H76O35 requires: C, 48.54; H, 6.19); Rf = 0.42 (6:3:1 CH3CN-H2O-NH4OH); [α]D = +124.2 (c 1.0 
in DMSO); 1H NMR (500 MHz, DMSO): δ = 7.26-7.12 (m, 4 H, Ph), 5.73-5.61 (m, 7 H, OH-6), 5.14, 
4.88 (2 d, 2 H, 2JH,H = 14.3 Hz, CHPh), 5.06 (d, 1 H, J1,2 = 3.7 Hz, H-1I), 5.05, 4.94 (2 d, 2 H, 2JH,H = 14.3 
Hz, CHPh), 4.83-4.78 (m, 6 H, H-1II-VII), 4.57-4.32 (m, 14 H, OH-2, OH-3), 3.80 (t, 1 H, J2,3 = J3,4 = 8.9 
Hz, H-3I), 3.68 (m, 1 H, H-6aI), 3.64-3.48 (m, 23 H, H-6bI, H-5I,H-4I, H-2I, H-3 II-VII, H-5II-VII, H-6aI-VII), 
3.35-3.21 (m, 18 H, H-4II-VII, H-6bII-VII, H-2II-VII); 1H 1DTOCSY (H-3I irradiation): δ = 5.06 (d, 1 H, H-1I), 
4.50 (m, 2 H, OH-2, OH-3), 3.68 (m, 1 H, H-6aI), 3.58 (m, 1 H, H-6bI), 3.54 (m, 1 H, H-5I), 3.52 (t, 1 H, 
J4,5 = 9.5 Hz, H-4I), 3.49 (dd, 1 H, J2,3 = 8.9 Hz, H-2I); 13C NMR (125.7 MHz, DMSO): δ = 137.1-128.3 
(Ph), 102.4 (×3), 102.3, 102.1 (×2) (6 C, C-1II-VII), 100.6 (C-1I), 82.5, 82.1 (×2), 81.8 (×2), 81.7 (6 C, C-
4II-VII), 81.7 (C-3I), 81.0 (C-2I), 79.1 (C-4I), 73.8, 73.7 (×3), 73.6, 73.4 (6 C, C-3II-VII), 73.7 (CH2Ph), 73.2 
(C-5I), 73.1 (CH2Ph),  73.0, 72.9, 72.8 (×2), 72.7 (×2), (6 C, C-2II-VII), 72.6, 72.5 (×4), 72.1 (6 C, C-5II-VII),  
60.6, 60.5 (×2), 60.3 (×3) (6 C, C-6II-VII), 60.1 (C-6I). FABMS: m/z 1259 ([M + Na]+). 
2I, 3I-O-(o-Xylylene)cyclomaltooctaose (6). Isolated as an amorphous solid (Found: C, 47.95; H, 
6.06; C56H86O40 requires: C, 48.07; H, 6.19); Rf = 0.52 (CH3CN-H2O-NH4OH 6:3:1); [α]D = +154.8 (c 
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0.91 in H2O). 1H NMR (500 MHz, D2O): δ = 7.10-6.96 (m, 4 H, Ph), 5.28 (d, 1 H, J1,2 = 3.7 Hz, H-1I), 
5.20, 4.73 (2 d, 2 H, 2JH,H = 13.4 Hz, CHPh), 5.16, 5.09 (2 d, 2 H, 2JH,H = 14.0 Hz, CHPh), 5.12-4.98 (m, 
7 H, H-1II-VIII), 4.13-4.03 (m, 7 H, H-5II-VIII), 3.97-3.62 (m, 27 H, H-3I-VIII, H-6aI-VIII, H-6bI-VIII, H-5I, H-4I, 
H-2I), 3.63-3.47 (m, 14 H, H-2II-VIII, H-4II-VIII); 1H 1DTOCSY (H-1I irradiation): δ = 3.93 (t, 1 H, J2,3 = 
J3,4 = 8.3 Hz, H-3I), 3.92 (m, 2 H, H-6aI, H-5I), 3.89 (d, 1 H, J6a,6b = 11.5 Hz, H-6bI), 3.79 (m, 1 H, H-2I),  
3.75 (m, 1 H, H-4I); 13C NMR (125.7 MHz, D2O): δ = 136.2-128.0 (Ph), 102.3, 102.2, 102.0, 101.7, 101.6, 
101.0 (×2) (7 C, C-1II-VIII), 100.3 (C-1I), 81.7, 81.1, 80.5, 80.0, 79.8, 79.6, 79.2, 79.1 (8 C, C-4I-VIII), 79.1 
(C-2I), 78.4 (C-3I), 73.8 (CH2Ph), 73.7, 73.5, 73.2, 72.9 (×2), 72.8, 72.7, 72.6, 72.5 (×2), 72.3, 72.1, 72.0 
(×3), 71.9 (×3), 71.8 (×3), 71.7 (22 C, C-2II-VIII, C-3II-VIII, C-5I-VIII), 60.5 (×2), 60.3 (×3), 60.1 (×2), 59.9 (8 
C, C-6I-VIII); ESIMS: m/z 1421.3 ([M + Na]+). 
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Heptakis(6-O-tert-butyldimethylsilyl)-2I,3I-O-(o-xylylene)cyclomaltoheptaose (7). To a 
solution of 5 (300 mg, 0.24 mmol) in dry pyridine (3 mL), TBDMSCl (304 mg, 2.02 mmol) was added. 
The reaction mixture was stirred at room temperature for 24 h, then concentrated and the resulting residue 
was purified by column chromatography using 60:1→6:1 CH2Cl2-MeOH (0.5% Et3N) as eluent, to yield 
7 (458 mg, 93%) as an amorphous solid (Found: C, 53.98; H, 8.36; C92H174O35Si7 requires: C, 54.25; H, 
8.61); Rf = 0.34 (9:1 CH2Cl2-MeOH); [α]D = +133.8 (c 0.73 in CHCl3); 1H NMR (500 MHz, CD3OD): δ 
= 7.29-7.156 (m, 4 H, Ph), 5.28, 4.99 (2 d, 2 H, 2JH,H = 14.1 Hz, CHPh), 5.12, 5.07 (2 d, 2 H, 2JH,H = 14.7 
Hz, CHPh), 5.12 (d, 1 H, J1,2 = 3.7 Hz, H-1I), 5.01-4.94 (m, 6 H, H-1II-VII), 4.11-3.91 (m, 8 H, H-6aI-VII, 
H-3I), 3.90-3.82 (m, 6 H, H-3II-VII), 3.79-3.73 (m, 7 H, H-6bI-VII), 3.69-3.64 (m, 8 H, H-5I-VII, H-4I), 3.59-
3.52 (m, 7 H, H-4II-VII, H-2I), 3.44-3.36 (m, 6 H, H-2II-VII), 0.89 (s, 63 H, (CH3)3C), 0.02 (s, 42 H, 
(CH3)2Si); 1H TOCSY (H-1I irradiation): δ = 4.11 (bd, 1 H, J6a,6b = 11.5 Hz, H-6aI), 3.97 (m, 1 H, H-3I), 
3.76 (m, 1 H, H-6bI), 3.69 (m, 2 H, H-4I, H-5I), 3.54 (dd, 1 H, J2,3 = 8.8 Hz, H-2I); 13C NMR (125.7 MHz, 
CD3OD): δ = 136.3-127.8 (Ph), 102.4, 102.3 (×2), 102.2, 101.9, 101.6 (6 C, C-1II-VII), 100.7 (C-1I), 81.7, 
81.0, 80.9, 80.8 (×2), 80.7 (6 C, C-4II-VII), 80.8 (C-2I), 80.4 (C-3I), 78.4 (C-4I), 73.7, 73.6, 73.4, 73.3, 73.2 
(×2) (6 C, C-3II-VII), 73.2 (CH2Ph), 73.1, 73.0 (×2), 72.9 (x3) (6 C, C-2II-VII), 72.9 (CH2Ph), 72.7 (x2), 
72.5 (×3), 72.4 (6 C, C-5II-VII), 72.1 (C-5I), 62.2, 62.1, 61.9 (×4) (6 C, C6II-VII), 61.8 (C-6I), 25.2 (21 C, 
(CH3)3C), 17.9 (7 C, (CH3)3C); FABMS: m/z 2059 ([M + Na]+). 
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Heptakis(6-O-tert-butyldimethylsilyl)-2II-VII,3II-VII-dodeca-O-methyl-2I,3I-O-(o-
xylylene)cyclomaltoheptaose (8). Compound 7 (114 mg, 0.06 mmol) was dissolved in dry DMF (4.5 
mL). NaH (60% in mineral oil, 134 mg, 3.36 mmol) and MeI (209 mL, 3.36 mmol) were then added at 0 
ºC under Ar and the reaction mixture was stirred at room temperature for 2 h, then quenched with water 
(10 mL) and extracted with Et2O (4 × 10 mL). The combined organic layers were washed with water (3 × 
5 mL), dried (Na2SO4), concentrated and purified by column chromatography (1:4→1:3 EtOAc-
petroleum ether) to yield 8 (69 mg, 56%) as an amorphous solid (Found: C, 56.62; H, 8.78; 
C104H198O35Si7 requires: C, 56.64; H, 9.05); Rf = 0.34 (1:3 EtOAc-petroleum ether); [α]D = +96.9 (c 1.0 in 
CHCl3); 1H NMR (500 MHz, CDCl3): δ = 7.22-7.05 (m, 4 H, Ph), 5.26, 4.73 (2 d, 2 H, 2JH,H = 12.7 Hz, 
CHPh), 5.18, 5.12 (2 d, 2 H, 2JH,H = 11.6 Hz, CHPh), 5.19-5.12 (m, 7 H, H-1I-VII), 4.10-4.01 (m, 7 H, H-
6aI-VII), 3.79 (m, 1 H, H-3I), 3.79-3.61 (m, 6 H, H-4II-VII), 3.61-3.47 (m, 8 H, H-6bI-VII, H-4I), 3.59-3.35 (m, 
14 H, H-5I-VII, H-3II-VII, H-2I), 3.11-3.00 (m, 6 H, H-2II-VII), 3.75, 3.70, 3.64, 3.62, 3.57, 3.56, 3.52, 3.50, 
3.49, 3.47, 3.43, 3.25 (12s, 36 H, Me), 0.85 (s, 63 H, (CH3)3C), 0.01 (s, 42 H, (CH3)2Si); 1H 1DTOCSY 
(H-3I irradiation): δ = 5.15 (d, 1 H, J1,2 = 3.5 Hz, H-1I), 4.10 (d, 1 H, J6a,6b = 12.2 Hz, H-6aI), 3.61 (d, 1 H, 
H-6bI), 3.56 (t, 1 H, J3,4 = J4,5 = 9.5 Hz, H-4I), 3.53 (m, 1 H, H-5I), 3.41 (dd, 1 H, J2,3 = 9.0 Hz, H-2I); 13C 
NMR (125.7 MHz, CDCl3): δ = 138.4-126.8 (Ph), 99.8 (C-1I), 98.6, 98.2, 98.1 (×2), 98.0, 97.9 (6 C, C-
1II-VII), 82.3 (×6), 82.2, 82.0 (×3), 81.8 (×2) (12 C, C-2 II-VII, C-3II-VII), 82.0 (C-2I), 80.2, 79.2, 78.8, 78.7, 
78.6, 78.5, 78.2 (7 C, C-4I-VII), 79.0 (C-3I), 74.8 (CH2Ph), 72.4 (CH2Ph), 72.3 (C-5I), 72.3, 72.2 (×3), 72.0, 
71.9 (6 C, C-5II-VII), 62.6 (×2), 62.3 (×2), 62.2 (×2), 61.7 (×2), 61.5 (×2), 61.4 (×2), 61.3, 58.8, 58.7, 58.6 
(×3), 58.5 (19 C, C-6I-VII, Me), 26.0 (21 C, (CH3)3C), 18.5 (7 C, (CH3)3C); MALDI-TOFMS: m/z 2226.2 
([M + Na]+). 
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2II-VII,3II-VII-Dodeca-O-methyl-2I,3I-O-(o-xylenylene)cyclomaltoheptaose (9). A solution of 8 
(170 mg, 0.08 mmol) in TFA-H2O (1:1, 10 mL) was stirred at 45 ºC for 2 h. The acid was eliminated by 
coevaporation with water under reduced pressure and the resulting residue was dissolved in water and 
freeze dried to give 9 (108 mg, 96%) as a white foam (Found: C, 52.77; H, 7.15; C62H100O35 requires: C, 
52.98; H 7.17); Rf = 0.47 (10:1:1 CH3CN-H2O-NH4OH); [α]D = +108.7 (c 1.0 in H2O); 1H NMR (500 
MHz, D2O): δ = 7.35-7.14 (m, 4 H, Ph), 5.25 (d, 1 H, J1,2 = 3.4 Hz, H-1I), 5.35-5.19 (m, 6 H, H-1II-VII), 
5.09, 4.98 (2 d, 2 H, 2JH,H = 14.7 Hz, CHPh), 4.85 (bs, 2 H, CH2Ph), 3.92-3.76 (m, 7 H, H-6aI-VII), 3.79-
3.68 (m, 7 H, H-6bI-VII), 3.79-3.62 (m, 7 H, H-5I-VII), 3.78-3.38 (m, 7 H, H-3I-VII), 3.67-3.52 (m, 7 H, H-4I-
VII), 3.39-3.21 (m, 7 H, H-2I-VII), 3.60 (×2), 3.55, 3.52, 3.50, 3.49, 3.42, 3.41, 3.27 (×4) (7 s, 36 H, 12 
Me); 1H 1DTOCSY (H-1I irradation): δ =  3.90 (m, 1 H, H-6aI), 3.78 (m, 2 H, H-3I, H-5I), 3.74 (m, 1 H, 
H-6bI), 3.62 (m, 1 H, H-4I), 3.39 (dd, 1 H, H-2I); 13C NMR (125.7 MHz, D2O): δ = 136.8-128.0 (Ph), 98.1 
(x2), 97.9, 97.6, 96.7, 96.0 (6 C, CII-VII), 97.8 (C-1I), 81.9, 81.8, 81.4 (x2), 81.2, 80.9 (6 C, C-3II-VII), 80.8, 
80.5, 80.4, 80.3, 80.2 (×2) (6 C, C-2II-VII), 80.2 (C-2I), 79.9 (C-3I), 78.6, 78.3 (×3), 76.8, 75.4, 75.0 (7 C, 
C-4I-VII), 73.3, 73.0 (2 C, CH2Ph), 70.2, 71.9 (×2), 71.8 (×2), 71.6, 70.5 (7 C, C-5I-VII), 60.7 (×2), 60.6 
(×4), 60.5, 60.4 (×2), 60.3 (×3), 60.2, 59.6, 58.4 (×2), 58.1 (×3) (19 C, C-6I-VII, Me); FABMS: m/z 1428 
([M + Na]+). 
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2II-VII,3II-VII,6I-VII-Nonadeca-O-methyl-2I,3I-O-(o-xylylene)cyclomaltoheptaose (10). To a solution 
of 5 (192 mg, 0.16 mmol) in dry DMF (12 mL), NaH (60% in mineral oil, 589 mg, 14.73 mmol) and MeI 
(917 μL, 14.73 mmol) were carefully added at 0 ºC under Ar. The reaction mixture was stirred for 12 h, 
then quenched with water (15 mL) and extracted with Et2O (4 × 15 mL). The combined organic layer 
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were washed with water (3 × 10 mL), dried (Na2SO4), concentrated and purified by column 
chromatography (20:1 CH2Cl2-MeOH) to yield 10 (243 mg, 99%) as an amorphous solid (Found: C, 
54.93; H, 7.46; C69H114O35 requires: C, 55.12; H 7.64); Rf = 0.23 (CH2Cl2: MeOH 20:1); [α]D = +164.3 (c 
1.0 CHCl3); 1H NMR (500 MHz, D2O): δ = 7.25-7.13 (m, 4 H, Ph), 5.26-5.14 (m, 7 H, H-1I-VII), 4.98, 
4.91 (2 d, 2 H, 2JH,H = 14.6 Hz, CHPh), 4.95, 4.92 (2 d, 2 H, 2JH,H = 14.5 Hz, CHPh), 3.85 (m, 1 H, H-6aI), 
3.79-3.67 (m, 6 H, H-6aII-VII), 3.68-3.52 (m, 7 H, H-4I-VII), 3.66-3.43 (m, 7 H, H-6bI-VII), 3.64-3.43 (m, 8 
H, H-3I-VII, H-2I), 3.58-3.40 (m, 7 H, H-5I-VII), 3.28-3.17 (m, 6 H, H-2II-VII), 3.57, 3.53, 3.48, 3.47, 3.44, 
3.43, 3.41, 3.38 (×2), 3.36, 3.27 (×3), 3.26 (×3), 3.25, 3.23, 3.17 (15 s, 57 H, Me); 1H 1DTOCSY (H-6aI 
irradiation): δ = 5.17 (d, 1 H, J1,2 = 3.7 Hz, H-1I), 3.78 (t, 1 H, J2,3 = J3,4 = 9.5 Hz, H-3I), 3.67 (dd, 1 H, 
J6a,6b = 11.0 Hz, J5,6b = 4.0 Hz,H-6bI), 3.60 (t, 1 H, J4,5 = 10.5, H-4I), 3.57 (m, 1 H, H-5I), 3.44 (dd, 1 H, 
H-2I); 13C NMR (125.7 MHz, D2O): δ = 136.7-128.1 (Ph), 98.1 (C-1I), 97.7, 97.6, 97.5, 97.3, 96.7, 96.2 
(6 C, C-1II-VII), 81.6, 81.5, 81.2 (×2), 81.0 (×2) (6 C, C-3II-VII), 80.5, 80.3, 80.2 (x4) (6 C, C-2II-VII), 79.9 
(C-3I), 79.2 (C-2I),  77.9 (x2), 77.8, 77.7, 76.9, 76.0, 75.6 (7 C, C-4I-VII), 73.3 (CH2Ph), 72.4 (CH2Ph), 
70.6 (×5), 70.5 (×2) (7 C, C-5I-VII), 70.9, 70.8, 70.6, 70.5 (×2), 70.4 (6 C, C-6II-VII),  69.5 (C-6I),  60.2, 
60.6 (×2), 60.0 (×2), 59.7, 58.5, 58.4 (×8), 58.3, 58.2, 58.0 (×2) (19 C, Me); FABMS: m/z 1526 ([M + 
Na]+). 
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11  
2II-VII,3II-VII,6I-VII-Nonadeca-O-methylcyclomaltoheptaose (11). To a solution of 10 (243 mg, 
0.16 mmol) in 1:1 EtOAc-MeOH (10 mL) and aq HCOOH (10%, 1.6 mL), 10% Pd/C (80 mg) was added. 
The resulting suspension was hydrogenated at 1 atm for 16 h, then filtered through Celite, concentrated 
and the resulting residue purified by column chromatography (10:1 CH3CN-H2O→10:1:0.5 CH3CN-H2O-
NH4OH) to yield 11 (137 mg, 60%) as an amorphous solid (Found: C, 52.32; H, 7.78; C61H108O35 
requires: C 52.28, H 7.77); Rf = 0.42 (10:1:0.5 CH3CN-H2O-NH4OH); [α]D = +158.7 (c 1.0 in CHCl3); 1H 
NMR (500 MHz, D2O): δ = 5.18-5.14 (m, 6 H, H-1II-VII), 4.94 (d, 1 H, J1,2 = 3.6, H-1I), 3.80-3.64 (m, 8 H, 
H-6aI-VII, H-3I), 3.66-3.63 (m, 6 H, H-4II-VII), 3.66-3.43 (m, 10 H, H-6bI-VII, H-4I, H-5I, H-2I), 3.62-3.53 
(m, 6 H, H-3II-VII), 3.29-3.21 (m, 6 H, H-2II-VII), 3.52, 3.49 (x5), 3.43, 3.40 (x4), 3.27 (x4), 3.26 (x4) (7 s, 
57 H, Me); 1H 1DTOCSY (H-1I irradiation): δ = 3.79 (t, 1 H, J2,3 = J3,4 = 9.5 Hz, H-3I), 3.64 (dd, 1 H, 
J6a,6b = 11.5 Hz, H-6aI), 3.57 (m, 1 H, H-6bI), 3.50 (m, 2 H, J4,5 = 9.5 Hz, H-4I, H-5I), 3.45 (dd, 1 H, H-
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2I); 13C NMR (125.7 MHz, D2O): δ = 100.3 (C-1I), 98.2, 97.6, 97.4, 97.1, 96.9, 96.8 (6 C, C-1II-VII), 81.5, 
81.2, 81.1, 80.9 (×2), 80.7, 80.4, 80.2 (×3), 80.0 (×2) (12 C, C-2II-VII, C-3II-VII), 77.8, 77.3 (×3), 77.0 (×2), 
76.6 (7 C, C-4I-VII), 73.0 (C-3I), 71.8 (C-2I),  70.8 (×4), 70.7, 70.6, 70.5, 70.4 (×3), 70.3 (×2), 70.2 (14 C, 
C-5I-VII, C-6I-VII), 60.3, 59.8 (×2), 59.7, 59.5, 59.4, 58.9, 58.4 (×6), 58.2 (×3), 58.1 (×2), 58.0 (19 C, Me); 
ESIMS: m/z 1423 ([M + Na]+). 
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12  
2I,3I-Di-O-acetyl-2II-VII,3II-VII,6I-VII-nonadeca-O-methylcyclomaltoheptaose (12). Compound 11 
(80 mg, 0.06 mmol) was dissolved in Ac2O-pyridine (1:1, 1 mL) and stirred at 45 ºC for 4 days. H2O (10 
mL) was then added and the mixture was extracted with CH2Cl2 (4 × 5 mL). The combined organic layer 
was washed with H2SO4 (2 M, 3 × 5 mL), saturated aqueous NaHCO3 (2 × 5 mL), dried (Na2SO4), 
filtered and concentrated. The residue was purified by column chromatography (20:1 CH2Cl2-MeOH) to 
yield 12 (53 mg, 60%) as an amorphous solid (Found: C, 52.46; H, 7.71; C65H112O37 requires: C, 52.55; H, 
7.60) Rf = 0.18 (20:1 CH2Cl2-MeOH); [α]D = +145.2 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3): δ = 
5.51 (dd, 1 H, J2,3 = 10.6 Hz, J3,4 = 9.4 Hz,  H-3I), 5.21 (d, 1H, J1,2 = 3.6 Hz, H-1I), 5.15-4.93 (m, 6 H, H-
1II-VII), 4.76 (dd, 1 H, H-2I), 3.98 (dd, 1 H, J5,6b = 10.9 Hz, J5,6a = 3.5 Hz, H-6aI),  3.87-3.71 (m, 14 H, H-
4I-VII, H-6aII-VII, H-5I), 3.60-3.44 (m, 13 H, H-5II-VII, H-6bI-VII), 3.53-3.48 (m, 6 H, H-3II-VII), 3.63, 3.62, 
3.60, 3.58, 3.55, 3.53, 3.48, 3.46 (x4), 3.42, 3.37, 3.35 (x6) (12 s, 57 H, Me), 3.17-3.05 (m, 6 H, H-2II-VII), 
2.06 (2 s, 6 H, OAc); 1H 1DTOCSY (H-1I irradiation): δ = 5.51 (dd, 1 H, H-3I),  4.76 (dd, 1 H, H-2I), 
3.98 (dd, 1 H, H-6aI), 3.86 (m, 1 H, H-5I), 3.75 (t, 1 H, J4,5 = 9.5 Hz, H-4I), 3.55 (d, 1 H, H-6bI); 13C 
NMR (125.7 MHz, CDCl3): δ = 170.7, 170.2 (CO), 99.5, 99.3, 98.9 (x4) (6 C, C-1II-VII), 98.2 (C-1I), 82.7, 
82.4, 82.1, 82.0, 81.9, 81.8 (6 C, C-2II-VII), 81.7 (×3), 81.5 (×2), 81.2 (6 C, C-3II-VII), 80.7, 80.6, 80.4 (x2), 
79.6 (×2) (6 C, C-4II-VII), 78.6 (C-4I), 71.8, 71.6, 71.5 (×2), 71.4, 71.3, 71.2, 71.0, 70.9 (×2), 70.8 (12 C, 
C-5 II-VII, C-6II-VII), 71.4 (C-2I), 70.6 (C-6I), 69.7 (C-3I), 61.6 (C-5I), 61.5 (×2), 61.4, 61.2, 60.3, 59.1, 59.0, 
58.9 (×6), 58.7 (×2), 58.6 (×2), 58.3 (×2) (19 C, Me), 21.0, 20.8 (2 C, OAc); ESIMS: m/z 1507.7 ([M + 
Na]+); 1523.7 ([M + K]+). 
NMR Aggregation Studies for 10: Comparative 1H NMR experiments for 10 in D2O at different 
concentrations (range 1 to 14 mM) and temperatures (range 25 to 80 ºC) confirmed the formation of 
aggregates. The aggregation process was fully reversible and was disrupted in CDCl3 solution, supporting 
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the hydrophobic nature of the interactions at work during aggregation. The high temperature spectra 
resemble the spectra at low concentration and, conversely, the spectra al low temperatures resembled 
those at high concentration, in agreement with a thermodynamically favoured association. From the 
chemical shift variations of spectra recorded at 25 ºC for different concentrations, an association number 
n = 2 was derived. 
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Comparative NMR Inclusion Studies for 10 and TRIMEB: The association constants at 298 K in 
D2O were experimentally determined by measuring the proton chemical shift changes of 3 mM solutions 
of the capped cyclodextrin receptor 10 or heptakis(2,3,6-tri-O-methyl)cyclomaltoheptaose (TRIMEB) 
upon increased amounts of the guest (OG). Smooth variations of the chemical shifts as a function of the 
host:guest ratio were observed. The absence of new peaks arising from the complex indicated that the 
inclusion process is in a fast exchange regime in the NMR time scale. In a typical titration experiment, a 3 
mM solution of host in D2O was prepared, a 500-μL aliquot was transferred to a 5-mm NMR tube, and 
the initial NMR spectrum was recorded. A solution (25-50 mM) of guest in the previous host solution was 
prepared and then added via microsyringe initially in 10 μL portions. These amounts were increased until 
complete complexation of the host. The 1H NMR spectrum of each solution was recorded and the 
chemical shift of the diagnostic sugar protons obtained at 12-15 different host-guest concentration ratios 
were used in an iterative least-squares fitting procedure (see, e.g., Figure 1S). 
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Figure 1S. Binding isotherm for the 10:OG complex. A three-dimensional model showing the spatial proximity between 
the sugar moiety in OG (in blue) and the xylylene moiety in 10, assuming inclusion of the hydrocarbon chain (in orange) in the 
cavity, is depicted. This proximity is probably translated into stabilising interactions that, are their turn, would explain the 
three-fold increase in Kas when compared with the analogous TRIMEB:OG complex (Kas = 112 ± 5 M-1). 
 
Fluorescence Aggregation Studies for 10: Fluorescence decay measurements were performed on a 
TCSPC FL900 Edinburgh Instruments Spectrometer by using a thyratron-gated lamp filled with hydrogen 
and equipped with two concave grating monochromators at both the excitation and emission paths and a 
red sensitive photomultiplier immersed in a Peltier cooled housing. The data acquisition was carried out 
by using 1024 channels and a time window width of 200 ns with a total of 10.000 counts at the maximum 
peak of intensity. The instrumental response function was regularly obtained by measuring the scattering 
of a Ludox solution. Temperature was controlled (Techne TE-8A). Right angle geometry, magic angle 
and cylindrical 2 mm diameter cells were used. Al measurements were performed in the range of 
temperatures from 5 to 45 ºC at 10 ºC intervals. 
Decay intensity profiles were fitted to a sum of exponential decay functions as 
 
i
n
t /
i
i 1
I(t) A e (1)−
=
= ∑ τ  
by the iterative reconvolution method. The average lifetime of a multiple-exponential decay function was 
then defined as  
n
2
i i
i 1
n
i i
i 1
A
(2)
A
τ
τ
τ
=
=
=
∑
∑  
where Ai is the pre-exponential factor of the component with a lifetime τi of the multi-exponential function 
intensity decay. 
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The fractional contribution fi of each decay time to the steady-state intensity which represents the 
fraction of total fluorescence intensity, I of i-component at the wavelength of observation is given by 
i i i
i i i
i=1 i=1
A τ I (3)
A τ Ii
f = =∑ ∑  
The intensity weighted average lifetime <τ> from a dilute solution of a pair of emitting species, 1 and 2, 
that do not interact during excited state lifetime can be obtained as 
1 1 2 2 (4)τ = τ + τf f  
For the dimer formation equilibrium 
2 CD CD2     (5) 
described by the following association constant 
2
2
[CD ]                  (6)
[CD]
K =  
the [CD2] and [CD] at the equilibrium can be obtained as 
[ ] 0 02 (4 [CD] +1) - 8 [CD] +1CD = 8
K K
K
    (7) 
and 
[ ] 08 [CD] +1 1CD =
4
−K
K
    (8) 
 
The total fluorescence intensity, measured as area under the emission spectra, can be written as sum 
of contribution due to the CD and CD2 dimer as 
[ ] [ ]
2 2
2
CD CD CD CDI = I + I = k CD + k CDKφ φ  (9) 
where k is a constant which depends on instrumental conditions: detector and monochromator response, 
geometry of the detection…, and 
2CD CD
andφ φ  are the proportionality constants between fluorescence 
and concentration of free CD and CD2, which are related to their fluorescence quantum yields and molar 
absorptivities at the excitation wavelength. 
By substitution of (8) into (9) and (3), from eq (4) the intensity weighted average lifetime <τ> from the 
CD and CD2 emission can be related to the initial [CD]0 by 
( )
( )2CD CD 00
8 [CD] +1 1
1 8 [CD] +1 1
τ ττ + Φ −= + Φ −
K
K
            (10) 
where Φ is proportional to the 
2CD CD
/φ φ ratio. 
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Figure 2S (a) depicts the variation of <τ> with [10] and temperature. Curves are fitted to equation 
(10) by assuming  Φ = 2, which reasonably reproduces de fluorescence intensity changes for [10]. The 
following parameters were obtained: 
 
Temperature (ºC) 
 
τmono (ns) τdimer (ns) K (M-1) 
5 4.8 ± 0.3 16.2 ± 0.9 260 ± 80 
15 4.6 ± 0.3 14.2 ± 0.8 239 ± 75 
25 4.4 ± 0.2 12.3 ± 0.9 200 ± 85 
35 4.3 ± 0.2 10.9 ± 1.4 122 ± 75 
45 4.0 ± 0.3 9.0 ± 2.4 77 ± 70 
 
 
ΔH0 (-22.7 ± 4.4 kJ/mol) and ΔS0 (-34 ± 15 J/Kmol) values were obtained from the linear van’t Hoff 
plot depicted in Figure 2S (b) by using the K values collected in Table 1. This is consistent with an 
enthalpy-driven dimerization process, enthropically disfavored. Figure 3S depicts three-dimetional 
models for the monomer in the “capped“ conformation and the corresponding dimer in the head-head 
(HH) arrangement. 
 
 
Figure 2S. Average lifetimes as a function of total concentration of 10 to determine K at different temperatures (a) and linear 
van't Hoff plot for the monomer-to-dimer equilibrium (b). 
 
 
Figure 3S. Three dimesional models for the monomeric and dimeric species present  in a water solution of  10. The monomer is 
depicted in the most stable “capped“ conformation and the dimer in the HH arrangement, in agreement with NMR data. Only the 
protons at the xylylene moiety are represented for clarity. 
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Figure 3S. 1H NMR spectrum (500 MHz, D2O, 333 K) of compound 4. 
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Figur3 4S. 13C NMR spectrum (125.7 MHz, D2O, 333 K) of compound 4. 
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Figure 5S. 1H NMR spectrum (500 MHz, DMSO-d6) of compound 5. 
 
# Supplementary Material (ESI) for Chemical Communications
# This journal is (c) The Royal Society of Chemistry 2007
 S15
72747678808284 ppm
C-1I
C-4IC-2I
C-3I
O
O
O
O
O
O
O
O
O
O
O
O
OH
HO
HO OH
OH
OH
OH
OH
OHOH
O
O
OH
HO
OHOH
OH
HO
n
n = 2
 
 
Figura 6S. 13C NMR spectrum (125.7 MHz, DMSO-d6) of compound 5. 
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Figure 7S. 1H NMR spectrum (500 MHz, D2O) of compound 6. 
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Figure 8S. 13C NMR spectrum (125.7 MHz, D2O) of compound 6. 
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Figura 9S. 1H NMR spectrum (500 MHz, CD3OD) of compound 7. 
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Figura 10S. 1H NMR spectrum (125.7 MHz, CD3OD) of compound 7. 
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Figura 11S. 1H NMR spectrum (500 MHz, CDCl3) of compound 8. 
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Figura 12S. 13C NMR spectrum (125.7 MHz, CDCl3) of compound 8. 
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Figure 13S. 1H NMR spectra (500 MHz, D2O) of compound 9. 
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Figure 14S. 13C NMR spectra (125.7 MHz, D2O) of compound 10. 
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Figure 15S. 1H NMR spectra (500 MHz, D2O, 298 K) of compound 10 at different concentrations. 
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Figure 16S. 1H NMR spectra (500 MHz, D2) of compound 10 (10 mM) at different temperatures. 
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Figure 17S. 13C NMR spectra (500 MHz, D2O, 298 K) of compound 10 
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Figure 18S. 1H NMR spectrum (500 MHz, D2O) of compound 11. 
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Figure 19S. 13C NMR spectrum (125.7 MHz, D2O) of compound 11. 
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Figura 20S. 1H NMR spectrum (500 MHz, CDCl3) of compound 12. 
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Figure 21S. 13C NMR spectrum (125.7 MHz, D2O) of compound 12. 
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